The arylacetyl acyl-CoA:amino acid N-acyltransferase was previously purified to homogeneity from bovine liver mitochondria, and partial sequences were obtained for peptides generated by cyanogen bromide cleavage of the enzyme. One of these sequences was used to design an oligonucleotide probe that w
Determination of the sequence of the aralkyl acyl-CoA:amino acid N-acyltransferase from bovine liver mitochondria
β Scribed by Vessey, Donald A. ;Lau, Eva
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 90 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0887-2082
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The acyl-CoAamino acid N-acyltransferases were partially purified from human liver mitochondria. The aralkyl transferase (ArAlk) had glycine conjugating activity toward the fol- Its kinetic properties and responses to salt were very similar to those of bovine ArAlk. Further, its molecular weight wa
Neither salicylate nor ibuprofen was a substrate or inhibitor of the long-chain fatty acid:CoA ligase. In contrast, all three xenobiotic-metabolizing medium-chain fatty acid:CoA ligases (XL-I, had activity toward salicylate. The K , value for salicylate was similar for all three forms (2 to 3 pM), b
## Abstract The purification of xenobiotic/mediumβchain fatty acid:CoA ligases (XMβligases) from human liver mitochondria resulted in the isolation of two chromatographically separable forms (HXMβA and HXMβB). These two forms were purified to near homogeneity, cleaved with cyanogen bromide, the res